Halo Healthcare Inc.
A diagnostics company for early detection of breast cancer with FDA, CE cleared risk assessment test and diagnostics test in development.
Halo HC is a 2012 restructured and recapitalized growth company, founded as NeoMatrix LLC. The Company provides women with early, affordable, noninvasive, breast cancer detection tests performed in Gyn offices. Early detection saves lives and reduces healthcare costs. FDA cleared HALO® Breast Test provides risk of developing breast cancer. The Aura lab assay is licensed IP for a biomolecular diagnostic test. Strong CPT codes exist for both.